VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EPC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EPCEdgewell Personal Care Company
$27.72$1.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEPCFinancials

Edgewell Personal Care Company (EPC) Financials

28Y historyFree accessUpdated daily

Revenue growth has deteriorated to -10.5% in 2026Q2, while operating margins have collapsed from 12.8% in 2024Q3 to 3.5% in 2026Q2.

EPC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98
Sales/Revenue2.11B2.22B2.25B2.25B2.17B2.09B1.95B2.14B2.23B2.3B2.36B2.42B4.45B4.47B4.57B4.65B4.25B4B4.33B3.37B3.08B2.99B2.81B2.23B1.74B1.69B1.91B1.87B1.92B
Revenue Growth %-5.3%-1.34%0.09%3.68%4.04%7.06%-8.94%-4.18%-2.78%-2.69%-2.45%-45.56%-0.41%-2.22%-1.69%9.35%6.21%-7.65%28.7%9.37%2.91%6.3%25.99%28.33%2.69%-11.5%2.24%-2.58%-
Cost of Goods Sold1.25B1.3B1.3B1.31B1.29B1.14B1.07B1.17B1.2B1.17B1.2B1.24B1.32B1.25B2.43B2.5B2.23B2.14B2.29B1.76B1.6B1.51B1.4B1.27B963.8M999.1M1.04B997.9M1B
COGS % of Revenue-58.4%57.59%58.22%59.46%54.43%54.82%54.85%53.77%51.01%50.89%51.11%29.73%27.98%53.19%53.81%52.47%53.53%52.95%52.31%51.87%50.58%49.92%57.07%55.4%58.97%54.54%53.3%52.26%
Gross Profit855M924.9M955.7M940.8M880.5M951.2M880.9M966.6M1.03B1.13B1.16B1.18B1.29B1.2B2.14B2.15B2.02B1.86B2.04B1.6B1.48B1.48B1.41B958.3M775.9M695.1M883.7M874.4M917.4M
Gross Margin %40.58%41.6%42.41%41.78%40.54%45.57%45.18%45.15%46.23%48.99%49.11%48.89%29%26.86%46.81%46.19%47.53%46.47%47.05%47.69%48.13%49.42%50.08%42.93%44.6%41.03%46.16%46.7%47.74%
Gross Profit Growth %--3.22%1.58%6.85%-7.43%7.98%-8.87%-6.42%-8.26%-2.93%-2.02%-8.23%7.55%-43.9%-0.36%6.26%8.65%-8.79%26.98%8.37%0.21%4.9%47%23.51%11.62%-21.34%1.06%-4.69%-
Operating Expenses747.4M828.3M756.4M713.8M698.2M711.3M704.9M722.8M1.03B1.13B1.16B1.18B1.29B1.2B2.14B2.15B2.02B1.86B2.04B1.6B1.48B1.48B1.41B958.3M775.9M695.1M883.7M874.4M654.9M
OpEx % of Revenue-37.25%33.56%31.7%32.15%34.08%36.15%33.76%46.23%48.99%49.11%48.89%29%26.86%46.81%46.19%47.53%46.47%47.05%47.69%48.13%49.42%50.08%42.93%44.6%41.03%46.16%46.7%34.08%
Selling, General & Admin606.3M671.7M662.1M638.7M627.4M632.7M625M622.9M688.4M710.8M749.4M938.7M906M811M1.34B1.38B1.23B1.16B1.28B1.02B970.8M969M954.1M633.6M431.5M453.9M509.5M561.6M581.5M
SG&A % of Revenue-30.21%29.38%28.37%28.89%30.31%32.06%29.09%30.81%30.93%31.73%38.77%20.37%18.16%29.28%29.71%28.88%28.93%29.57%30.4%31.55%32.41%33.92%28.38%24.8%26.79%26.62%30%30.26%
Research & Development58.5M57.6M58.4M58.5M55.5M57.8M55.3M53.5M61.1M67.6M71.9M71M69.5M69.3M112.5M108.3M97.1M90.5M91.7M70.7M74.2M69.9M74M51.5M37.1M46.4M49.9M48.5M46.6M
R&D % of Revenue-2.59%2.59%2.6%2.56%2.77%2.84%2.5%2.73%2.94%3.04%2.93%1.56%1.55%2.46%2.33%2.29%2.26%2.12%2.1%2.41%2.34%2.63%2.31%2.13%2.74%2.61%2.59%2.42%
Other Operating Expenses2M99M35.9M16.6M15.3M20.8M24.6M46.4M283.4M347.5M338.6M174.1M314.4M319.1M688.1M657.3M695.2M611M665.2M510.9M435.8M438.8M380.6M273.2M307.3M194.8M324.3M264.3M26.8M
Operating Income35M96.6M199.3M227M182.3M239.9M176M243.8M283.4M347.5M338.6M174.1M314.4M319.1M688.1M657.3M695.2M611M665.2M510.9M435.8M438.8M380.6M273.2M307.3M194.8M324.3M255.8M262.5M
Operating Margin %1.66%4.34%8.84%10.08%8.39%11.49%9.03%11.39%12.68%15.12%14.34%7.19%7.07%7.15%15.07%14.15%16.36%15.28%15.36%15.18%14.16%14.68%13.53%12.24%17.66%11.5%16.94%13.66%13.66%
Operating Income Growth %--51.53%-12.2%24.52%-24.01%36.31%-27.81%-13.97%-18.45%2.63%94.49%-44.62%-1.47%-53.63%4.69%-5.45%13.78%-8.15%30.2%17.23%-0.68%15.29%39.31%-11.1%57.75%-39.93%26.78%-2.55%-
EBITDA80.3M185.4M287.3M318.4M272.2M327M264.8M337.6M381M441.9M431.2M289.4M450.6M463.6M850.3M838.6M834.4M741.4M806.5M625.9M553.3M555.1M496.4M356.4M364.7M274.6M406.3M350.7M363.7M
EBITDA Margin %3.81%8.34%12.75%14.14%12.53%15.67%13.58%15.77%17.05%19.23%18.26%11.95%10.13%10.38%18.62%18.05%19.64%18.54%18.62%18.6%17.98%18.57%17.65%15.96%20.96%16.21%21.22%18.73%18.93%
EBITDA Growth %-70.14%-35.47%-9.77%16.97%-16.76%23.49%-21.56%-11.39%-13.78%2.48%49%-35.77%-2.8%-45.48%1.4%0.5%12.54%-8.07%28.85%13.12%-0.32%11.83%39.28%-2.28%32.81%-32.41%15.85%-3.57%-
D&A (Non-Cash Add-back)45.3M88.8M88M91.4M89.9M87.1M88.8M93.8M97.6M94.4M92.6M115.3M136.2M144.5M162.2M181.3M139.2M130.4M141.3M115M117.5M116.3M115.8M83.2M57.4M79.8M82M94.9M101.2M
EBIT600K96.8M197.4M226.2M195.5M215M148.5M-327.7M231.8M16.3M291.7M-358.9M264.8M332M692.7M527.4M668.8M590M654.5M510.9M435.8M438.8M380.6M273.2M307.3M194.8M324.3M255.8M0
Net Interest Income-71.4M-73.2M-76.5M-78.5M-71.4M-67.9M-61.2M-62.6M-68M-69.2M-71.8M-99.8M-119M-126.6M-122.2M-152.4M-125.4M-144.7M-181.3M0000000000
Interest Income00000000000000000000000000000
Interest Expense71.4M73.2M76.5M78.5M71.4M67.9M61.2M62.6M68M69.2M71.8M99.8M119M126.6M127.3M121.4M125.4M144.7M181.3M0000000000
Other Income/Expense-80M-73M-78.4M-79.3M-58.2M-92.8M-88.7M-634.1M-119.6M-400.4M-118.7M-632.8M-168.6M-113.7M-122.7M-251.3M-151.8M-165.7M-192M-76.7M-79.2M-50.1M-32.8M-35.6M-28.9M-163.3M-45.1M-7.6M0
Pretax Income-45M23.6M120.9M147.7M124.1M147.1M87.3M-390.3M163.8M-52.9M219.9M-458.7M145.8M205.4M565.4M406M543.4M445.3M473.2M434.2M356.6M388.7M347.8M237.6M278.4M31.5M279.2M248.2M262.5M
Pretax Margin %-2.14%1.06%5.36%6.56%5.71%7.05%4.48%-18.23%7.33%-2.3%9.31%-18.95%3.28%4.6%12.38%8.74%12.79%11.13%10.93%12.9%11.59%13%12.37%10.64%16%1.86%14.59%13.26%13.66%
Income Tax-18.3M-1.8M22.3M33M24.6M29.3M19.7M-18.1M60.5M-58.6M41.2M-162.6M28.1M50.2M156.5M144.8M140.4M147.5M143.9M112.8M95.7M108M86.8M67.7M92M70.5M99M88.4M54.3M
Effective Tax Rate %40.67%-7.63%18.44%22.34%19.82%19.92%22.57%4.64%36.94%110.78%18.74%35.45%19.27%24.44%27.68%35.67%25.84%33.12%30.41%25.98%26.84%27.78%24.96%28.49%33.05%223.81%35.46%35.62%20.69%
Net Income-77.8M25.4M98.6M114.7M99.5M117.8M67.6M-372.2M103.3M5.7M178.7M-275.3M356.1M407M408.9M261.2M403M297.8M329.3M321.4M260.9M280.7M261M169.9M186.4M-39M181.4M80M164.7M
Net Margin %-3.69%1.14%4.38%5.09%4.58%5.64%3.47%-17.38%4.62%0.25%7.57%-11.37%8.01%9.11%8.95%5.62%9.49%7.45%7.6%9.55%8.48%9.39%9.28%7.61%10.71%-2.3%9.48%4.27%8.57%
Net Income Growth %-191.85%-74.24%-14.04%15.28%-15.53%74.26%118.16%-460.31%1712.28%-96.81%164.91%-177.31%-12.51%-0.46%56.55%-35.19%35.33%-9.57%2.46%23.19%-7.05%7.55%53.62%-8.85%577.95%-121.5%126.75%-51.43%-
Net Income (Continuing)-30.7M25.4M98.6M114.7M99.5M117.8M67.6M-372.2M103.3M5.7M178.7M-296.1M117.7M155.2M408.9M261.2M403M297.8M329.3M321.4M260.9M280.7M261M169.9M186.4M-39M180.2M159.8M164.7M
Discontinued Operations0000000000020.8M238.4M251.8M000000000000000
Minority Interest00000000000000000000000000000
EPS (Diluted)-1.670.531.972.211.862.121.24-6.521.900.102.99-4.445.696.476.223.725.724.725.595.514.143.823.131.852.01-0.421.880.781.62
EPS Growth %-197.85%-73.1%-10.86%18.82%-12.26%70.97%119.02%-443.16%1800%-96.66%167.34%-178.03%-12.06%4.02%67.2%-34.97%21.19%-15.56%1.45%33.09%8.38%22.04%69.19%-7.96%578.57%-122.34%141.03%-51.85%-
EPS (Basic)-0.531.982.241.872.151.25-6.521.900.103.02-4.445.746.556.303.755.764.775.715.674.263.953.241.902.05-0.421.890.781.62
Diluted Shares Outstanding46.5M47.6M50.1M51.8M53.6M55.2M54.6M54.1M54.5M57.5M59.7M62M62.6M62.9M65.7M70.3M70.5M63.1M58.9M58.3M63.02M73.48M83.4M91.84M92.74M92.86M96.49M102.56M101.6M
Basic Shares Outstanding46.5M47.5M49.7M51.2M53.1M54.4M54.3M54.1M54.4M57.3M59.2M61.95M62M62.1M64.9M69.6M70M62.4M57.6M56.7M61.24M71.06M80.6M89.42M90.93M92.86M95.98M102.56M101.6M
Dividend Payout Ratio-115.35%31.14%27.46%32.76%21.73%------34.79%25.95%6.09%--------------

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetStrained
Cash FlowDeteriorating
Top Statement Risk

Persistent Revenue Stagnation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Persistent Revenue Contraction Trends

As evidenced by the most recent quarterly data, Edgewell's top-line performance has deteriorated significantly, with revenue growth falling to -10.5% in 2026Q2, marking a sharp acceleration in the negative trajectory compared to the -0.3% decline observed in the third quarter of the 2024 fiscal year.

The consistent pattern of negative year-over-year growth suggests that the company is struggling to maintain shelf velocity in its core categories. This trend implies that either competitive pressures from private-label alternatives or a broader shift in consumer spending habits is eroding the company's ability to sustain its historical revenue base.

Structural Margin Compression Risks

According to the provided income statement figures, Edgewell's gross margin has faced notable volatility, dropping from a peak of 44.3% in 2024Q3 to 41.8% in 2026Q2, which highlights the company's limited ability to pass through rising input costs to price-sensitive consumers in the personal care segment.

The inability to maintain gross margins above the 42% threshold suggests that the company's pricing power is currently insufficient to offset inflationary pressures on raw materials. Investors should monitor whether this margin erosion is a permanent feature of the current product mix or a temporary outcome of aggressive promotional activity intended to defend market share.

Operating Leverage Remains Highly Fragile

Based on reported financial statements, Edgewell's operating margin has collapsed from 12.8% in 2024Q3 to a mere 3.5% in 2026Q2, indicating that the company lacks the necessary operating leverage to protect profitability during periods of declining top-line revenue and elevated fixed cost requirements.

The sharp decline in operating income relative to gross profit suggests that SG&A expenses are not scaling down in proportion to revenue losses. This lack of cost flexibility appears to be a significant structural weakness that leaves the bottom line highly vulnerable to even minor fluctuations in quarterly sales volume.

Earnings Quality Impaired by Losses

As reported in recent filings, Edgewell has transitioned from consistent profitability to net losses, with the company recording a net loss of $10.6 million in 2026Q2, a stark reversal from the $49.0 million net income achieved in the third quarter of the 2024 fiscal year.

The shift into negative net income territory suggests that the company's current earnings quality is poor, as it is no longer generating positive returns for shareholders after accounting for all operating and non-operating expenses. This trend warrants further investigation into whether the company's restructuring efforts are failing to address the underlying cost inefficiencies.

EPC — Frequently Asked Questions

Quick answers to the most common questions about buying EPC stock.

What was Edgewell Personal Care Company's (EPC) revenue in 2025?

For fiscal year 2025, Edgewell Personal Care Company (EPC) reported total revenue of $2.22B. This represents a 15.7% increase compared to $1.92B in 1998.

Is Edgewell Personal Care Company (EPC) profitable?

Edgewell Personal Care Company (EPC) is profitable, generating $25.4M in net income for the fiscal year ending 2025 with a net profit margin of 1.1%.

What is Edgewell Personal Care Company's operating profit margin?

Edgewell Personal Care Company (EPC) reported an operating income of $96.6M, resulting in an operating profit margin of 4.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Edgewell Personal Care Company's gross profit and gross margin?

Edgewell Personal Care Company (EPC) generated $924.9M in gross profit for the year, representing a gross profit margin of 41.6%. This demonstrates the company's core pricing power and production efficiency.